decisionhealth Newsletters, Part B News - 2003 Issue 4 (April)
CMS: carrier can decide UPIN on chemotherapy billing
Subscribe or sign in to view the full article.
Article Overview
This article examines a CMS billing issue affecting chemotherapy infusion services and the physician identifier reported on claims. It explains why different carriers may handle the matter differently, highlights the relevance of Medicare incident-to billing requirements, and frames the discussion for oncology practices, compliance staff, and billing personnel who need to align claim reporting with local policy.
Why This Topic Matters
The topic matters because practices may be following different carrier approaches for the same service, and claim handling can affect compliance, documentation, and internal physician productivity tracking.
What You Will Learn
- How CMS is approaching the question of which physician identifier is reported for chemotherapy infusion billing
- Why carrier-specific billing policy is relevant to oncology practice claims
- How Medicare incident-to concepts are discussed in relation to chemotherapy services
- Why practices may choose different physician identifiers for administrative or tracking purposes
Who Should Read This
- Oncology billing staff
- Practice managers
- Compliance specialists
- Medical coders
- Revenue cycle professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com